Pentagon reports US achieves air superiority over Iran four days into operation
AI Sentiment
Negative
3/10
as of 03-04-2026 9:59am EST
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
| Founded: | 1806 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 64.0B | IPO Year: | 2007 |
| Target Price: | $95.06 | AVG Volume (30 days): | 5.6M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 2.63 | EPS Growth: | -25.07 |
| 52 Week Low/High: | $74.55 - $100.18 | Next Earning Date: | 05-01-2026 |
| Revenue: | $15,454,000,000 | Revenue Growth: | 1.70% |
| Revenue Growth (this year): | 7.59% | Revenue Growth (next year): | 3.31% |
| P/E Ratio: | 36.29 | Index: | |
| Free Cash Flow: | 3.5B | FCF Growth: | +2.48% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
COO, Eur., APac, Afr Eur, Skin
Avg Cost/Share
$97.81
Shares
15,000
Total Value
$1,467,111.00
Owned After
10,415
SEC Form 4
COO, Eur., APac, Afr Eur, Skin
Avg Cost/Share
$94.61
Shares
35,000
Total Value
$3,311,325.50
Owned After
10,415
SEC Form 4
Chief Growth Officer
Avg Cost/Share
$94.25
Shares
20,989
Total Value
$1,978,211.15
Owned After
17,645
SEC Form 4
EVP and Controller
Avg Cost/Share
$94.91
Shares
12,747
Total Value
$1,209,821.59
Owned After
11,879
SEC Form 4
Chief Human Resources Officer
Avg Cost/Share
$95.03
Shares
15,851
Total Value
$1,506,287.24
Owned After
13,751
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$94.27
Shares
97,843
Total Value
$9,223,287.81
Owned After
55,310
SEC Form 4
CLO and Secretary
Avg Cost/Share
$94.34
Shares
22,000
Total Value
$2,075,398.60
Owned After
76,406
SEC Form 4
Chairman, President & CEO
Avg Cost/Share
$93.91
Shares
45,568
Total Value
$4,279,495.94
Owned After
293,188
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Tsourapas Panagiotis | CL | COO, Eur., APac, Afr Eur, Skin | Feb 12, 2026 | Sell | $97.81 | 15,000 | $1,467,111.00 | 10,415 | |
| Tsourapas Panagiotis | CL | COO, Eur., APac, Afr Eur, Skin | Feb 11, 2026 | Sell | $94.61 | 35,000 | $3,311,325.50 | 10,415 | |
| Hazlin John | CL | Chief Growth Officer | Feb 10, 2026 | Sell | $94.25 | 20,989 | $1,978,211.15 | 17,645 | |
| Malcolm Gregory | CL | EVP and Controller | Feb 6, 2026 | Sell | $94.91 | 12,747 | $1,209,821.59 | 11,879 | |
| Massey Sally | CL | Chief Human Resources Officer | Feb 5, 2026 | Sell | $95.03 | 15,851 | $1,506,287.24 | 13,751 | |
| SUTULA STANLEY J III | CL | Chief Financial Officer | Feb 4, 2026 | Sell | $94.27 | 97,843 | $9,223,287.81 | 55,310 | |
| Daniels Jennifer | CL | CLO and Secretary | Feb 4, 2026 | Sell | $94.34 | 22,000 | $2,075,398.60 | 76,406 | |
| Wallace Noel R. | CL | Chairman, President & CEO | Feb 4, 2026 | Sell | $93.91 | 45,568 | $4,279,495.94 | 293,188 |
CL Breaking Stock News: Dive into CL Ticker-Specific Updates for Smart Investing
AI Sentiment
Negative
3/10
AI Sentiment
Neutral
4/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Neutral
4/10
AI Sentiment
Negative
3/10
AI Sentiment
Positive
6/10
AI Sentiment
Neutral
5/10
See how CL stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CL Colgate-Palmolive Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.